ReviewThe journal of allergy and clinical immunology. In practice2026
Risk Factors for Secondary Immunodeficiency in the Aged.
Review in The journal of allergy and clinical immunology. In practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Secondary immune deficiencies, in which the immune system is weakened or compromised by another factor, have become prevalent. Secondary immune deficiencies are particularly pertinent in aged people because numerous etiologies cause immune dysfunction in this population. Immunosenescence is characterized by inflammaging, cellular senescence, thymic involution, reduced naive T- and B-cell output, restricted antigen receptor diversity, and impaired innate immune cell function, leading to increased susceptibility to infection and diminished vaccine responsiveness. Malnutrition is common in aged people and exacerbates immune dysfunction through impaired cell-mediated immunity, micronutrient deficiencies, and weakened mucosal barriers. Immunosuppressive therapies are also frequently used in older adults, such as corticosteroids, cytotoxic agents, purine analogs, and biologics. Other comorbidities such as chronic kidney and liver disease, diabetes, cardiovascular disease, chronic lung disease, and persistent viral infections also contribute to immune dysregulation. Given these cumulative risks, vaccination remains a cornerstone of prevention. Updated immunization strategies targeting COVID-19, influenza, respiratory syncytial virus, herpes zoster, and pneumococcal disease are critical to reducing morbidity and mortality in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.